TR201901950A2 - Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ - Google Patents

Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ Download PDF

Info

Publication number
TR201901950A2
TR201901950A2 TR2019/01950A TR201901950A TR201901950A2 TR 201901950 A2 TR201901950 A2 TR 201901950A2 TR 2019/01950 A TR2019/01950 A TR 2019/01950A TR 201901950 A TR201901950 A TR 201901950A TR 201901950 A2 TR201901950 A2 TR 201901950A2
Authority
TR
Turkey
Prior art keywords
passiflora
magnesium
production method
treonate
methylpholate
Prior art date
Application number
TR2019/01950A
Other languages
English (en)
Turkish (tr)
Inventor
Yusubov Nati̇g
Original Assignee
Gmg Grand Medical Ilaclari Ltd Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gmg Grand Medical Ilaclari Ltd Sirketi filed Critical Gmg Grand Medical Ilaclari Ltd Sirketi
Priority to TR2019/01950A priority Critical patent/TR201901950A2/tr
Publication of TR201901950A2 publication Critical patent/TR201901950A2/tr
Priority to PCT/TR2020/050081 priority patent/WO2020162859A2/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2019/01950A 2019-02-08 2019-02-08 Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ TR201901950A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/01950A TR201901950A2 (tr) 2019-02-08 2019-02-08 Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇
PCT/TR2020/050081 WO2020162859A2 (fr) 2019-02-08 2020-02-07 Nouvelle combinaison contenant de la passiflore, de la glycine, du métylfolate et du thréonate de magnésium et son procédé de production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/01950A TR201901950A2 (tr) 2019-02-08 2019-02-08 Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇

Publications (1)

Publication Number Publication Date
TR201901950A2 true TR201901950A2 (tr) 2019-05-21

Family

ID=67954943

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/01950A TR201901950A2 (tr) 2019-02-08 2019-02-08 Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇

Country Status (2)

Country Link
TR (1) TR201901950A2 (fr)
WO (1) WO2020162859A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1028612B1 (fr) * 2021-02-24 2022-04-06 Vesale Pharmaceutica Composition comprenant un extrait de safran, un peptide de caseine et un autre compose vegetal pour le traitement des troubles du sommeil, des troubles de l'humeur ou de l'anxiete

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030012824A1 (en) * 2001-07-03 2003-01-16 Ott Dana Beth Orally administered anti-stress composition
AU2018292531A1 (en) * 2017-06-27 2020-02-13 Harmonix, Llc Time release sleep aid system
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas

Also Published As

Publication number Publication date
WO2020162859A2 (fr) 2020-08-13
WO2020162859A3 (fr) 2020-10-08

Similar Documents

Publication Publication Date Title
EA201270225A1 (ru) СОЕДИНЕНИЯ ДЛЯ УМЕНЬШЕНИЯ ПРОДУКЦИИ β-АМИЛОИДА
CU20210029A7 (es) Inhibidores de proteína tirosina fosfatasa shp2 útiles en el tratamiento de enfermedades
EA202092899A1 (ru) Гетероарильные соединения для лечения болезни гентингтона
MA42606B1 (fr) Sels d'un inhibiteur de lsd1
MX2012008626A (es) Composiciones y metodos para potenciar la actividad de proteasoma.
MA49760B1 (fr) Mavacamten pour l'utilisation dans le traitement de la cardiomyopathie hypertrophique
NO20063986L (no) Anti-CD-38-humane antistoffer og anvendelse derav
CL2008003004A1 (es) Anticuerpo anti-esclerostina o su porción de enlace de antígeno; polinucleotido que lo codifica; vector; célula; proceso de producción; composición farmacéutica que lo comprende; método para identificar células y su uso para tratar trastornos óseos.
EA201500802A1 (ru) Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы
MA41778A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
EA201890815A1 (ru) Аминокислотные композиции с модифицированным высвобождением для перорального введения
CN111712573A (zh) 针对骨硬化蛋白的适体及其用途
EA201990418A1 (ru) Производные оксадиазолопиридина для применения в качестве ингибиторов грелин-о-ацилтрасферазы (goat)
TR201901950A2 (tr) Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇
EA202190888A1 (ru) Пептид для применения в косметике
UA107200C2 (uk) ОДИНИЧНИЙ ВАРІАБЕЛЬНИЙ ДОМЕН ІМУНОГЛОБУЛІНУ ПРОТИ РЕЦЕПТОРА ТИПУ 1 TNFα
MX2016007407A (es) Peptidos resistentes a proteasa.
EA202190481A1 (ru) Трипептиды и лечение метаболических, сердечно-сосудистых и воспалительных заболеваний
EA201391097A1 (ru) СОЕДИНЕНИЯ ДЛЯ СНИЖЕНИЯ ВЫРАБОТКИ β-АМИЛОИДА
MX382357B (es) Métodos y composiciones para tratar infecciones fúngicas cutáneas.
MX2024012306A (es) Inhibidores lrrk2.
BR112023003059A2 (pt) Método de lavagem de roupas e uso de um método
MX2018014966A (es) Peptidos monolipidados resistentes a proteasas.
FR3052056B1 (fr) Composition comprenant un tensioactif anionique, un organosilane, une si-licone aminee et un polymere cationique associatif, et procede de traitement cosmetique
SA522431585B1 (ar) تركيبات تروفينتايد